Test to join the company's expansive portfolio of Quest AD-Detect® blood tests for assessing symptomatic patients Quest also launching a new multi-biomarker AD-Detect® lab-developed blood test with low 10% indeterminate rate, so more patients can receive an actionable insight SECAUCUS,...
Hence then, the article about quest diagnostics to offer fda cleared roche ptau217 blood test to assess alzheimer s disease pathology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology )
Also on site :
- Ageless Jane Seymour Takes Halloween Inspiration From 2 Iconic Roles—Dr. Quinn and ‘James Bond’s’ Solitaire
- iPhone Duo Launches in Santa Barbara
- Energy markets are adapting to the Iran war as a ‘forever conflict’ while oil producers keep supplies flowing and avoid ‘mutually assured destruction’